We’re here and we’re ready to get it done at CPHI!
We’re here and we’re ready to get it done at CPHI!
We missed the boss, Tim Tyson, this year, but the TriRx team brought their A-game as they always do at CPHI.
The marketing team at Afton Scientific has done a great job of designing and building their new booth for PDA. We always love to see a textured wall.
Thrilled to see the team at Wacker still using the creative we developed for them, pictured here at this year’s ESGCT.
Throwback to Nigel and Russell at the booth we developed for GSK at CPHI 2016 in Frankfurt.
A fascinating presentation from Dr. Hollanbaugh, highlighting the discussion around Interleukin-2 (IL-2) inhibitors, which have emerged as a pivotal class of therapeutic agents, particularly in the realm of immunology and oncology.
Day Two of TAS25 kicks off with a presentation by Professor Madelon Maurice from the Madelon Maurice Lab in Holland.
Peter Senter, Ph.D., Janine Schuurman, Ph.D., and Greg Thurber, Ph.D. — now that’s a lineup.
Peter Senter, Ph.D., is the keynote for TAS25. Peter joined Seattle Genetics in 1998 and was part of the research team focused on anticancer therapies before the company’s $43 billion sale to Pfizer in 2023.
So grateful to the team at FairJourney Biologics for inviting our team to TAS25, their high-science discovery show in Porto, Portugal.